Carl Dambkowski Insider Trading Activity
Carl Dambkowski has been net-selling over the last 12 months with 0 purchases and 29 sales across 2 different companies.
APGE is the most-traded position with 26 trades. The largest single transaction was a sale of ORKA for $3.2M on May 21, 2026.
Performance Scorecard
Forward stock performance after each transaction by Carl Dambkowski. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -9.2% | 30% | 33 |
| 90 days | — | -25.0% | 14% | 28 |
| 120 days | — | -41.1% | 0% | 25 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Carl Dambkowski bought and sold APGE.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 21, 2026 | ORKA | Sell | 38,318 | $58.43 | $2.2M | −21.4% | Director | |
May 21, 2026 | ORKA | Sell | 53,447 | $59.10 | $3.2M | −38.1% | Director | |
May 21, 2026 | ORKA | Sell | 13,235 | $59.97 | $794K | −15.2% | Director | |
May 6, 2026 | APGE | Sell | 3,700 | $83.92 | $311K | −1.7% | Chief Medical Officer | |
May 6, 2026 | APGE | Sell | 1,800 | $84.60 | $152K | −0.9% | Chief Medical Officer | |
Apr 1, 2026 | APGE | Sell | 2,698 | $84.31 | $227K | −1.3% | Chief Medical Officer | |
Apr 1, 2026 | APGE | Sell | 2,702 | $85.33 | $231K | −1.3% | Chief Medical Officer | |
Apr 1, 2026 | APGE | Sell | 100 | $85.89 | $9K | −0.0% | Chief Medical Officer | |
Mar 4, 2026 | APGE | Sell | 3,225 | $70.33 | $227K | −1.5% | Chief Medical Officer | |
Mar 4, 2026 | APGE | Sell | 2,075 | $71.98 | $149K | −1.0% | Chief Medical Officer | |
Mar 4, 2026 | APGE | Sell | 200 | $73.26 | $15K | −0.1% | Chief Medical Officer | |
Feb 4, 2026 | APGE | Sell | 2,481 | $64.88 | $161K | −1.1% | Chief Medical Officer | |
Feb 4, 2026 | APGE | Sell | 1,420 | $65.83 | $93K | −0.7% | Chief Medical Officer | |
Feb 4, 2026 | APGE | Sell | 1,299 | $66.85 | $87K | −0.6% | Chief Medical Officer | |
Feb 4, 2026 | APGE | Sell | 100 | $67.88 | $7K | −0.0% | Chief Medical Officer | |
Feb 4, 2026 | APGE | Sell | 200 | $68.94 | $14K | −0.1% | Chief Medical Officer | |
Jan 7, 2026 | APGE | Sell | 2,954 | $77.13 | $228K | −1.3% | Chief Medical Officer | |
Jan 7, 2026 | APGE | Sell | 14,820 | $77.90 | $1.2M | −6.5% | Chief Medical Officer | |
Jan 7, 2026 | APGE | Sell | 826 | $79.04 | $65K | −0.4% | Chief Medical Officer | |
Jan 7, 2026 | APGE | Sell | 100 | $80.06 | $8K | −0.0% | Chief Medical Officer | |
Dec 4, 2025 | APGE | Sell | 10,900 | $75.00 | $818K | −3.9% | Chief Medical Officer | |
Nov 5, 2025 | APGE | Sell | 2,300 | $53.62 | $123K | −0.8% | Chief Medical Officer | |
Nov 5, 2025 | APGE | Sell | 2,200 | $54.83 | $121K | −0.8% | Chief Medical Officer | |
Nov 5, 2025 | APGE | Sell | 5,607 | $55.58 | $312K | −1.9% | Chief Medical Officer | |
Nov 5, 2025 | APGE | Sell | 678 | $56.51 | $38K | −0.2% | Chief Medical Officer | |
Oct 1, 2025 | APGE | Sell | 5,110 | $39.80 | $203K | −1.8% | Chief Medical Officer | |
Sep 3, 2025 | APGE | Sell | 2,535 | $37.82 | $96K | −1.1% | Chief Medical Officer | |
Sep 3, 2025 | APGE | Sell | 190 | $38.55 | $7K | −0.1% | Chief Medical Officer | |
Aug 6, 2025 | APGE | Sell | 2,725 | $37.78 | $103K | −1.1% | Chief Medical Officer | |
Jul 2, 2025 | APGE | Sell | 6,409 | $44.77 | $287K | −2.6% | Chief Medical Officer | |
Jul 2, 2025 | APGE | Sell | 2,935 | $45.49 | $134K | −1.2% | Chief Medical Officer | |
Jul 2, 2025 | APGE | Sell | 746 | $46.26 | $35K | −0.3% | Chief Medical Officer | |
Jun 4, 2025 | APGE | Sell | 2,725 | $36.96 | $101K | −1.1% | Chief Medical Officer |
Top Companies Traded
Other insiders at Apogee Therapeutics, Inc.
2 other tracked filers at APGE.